High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引：0
作者：
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页码：374B / 375B
页数：2
相关论文
共 50 条
  • [11] Long term results of radioimmunotherapy with Bexxar/BEAM and autologous stem cell transplantation (ASCT) for chemotherapy resistant aggressive non-Hodgkin's lymphoma (NHL).
    Vose, JM
    Bierman, PJ
    Lynch, JC
    Bociek, GR
    Jacobs, C
    Armitage, JO
    BLOOD, 2003, 102 (11) : 248A - 248A
  • [12] High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplantation (ASCT) in patients with primary refractory aggressive Non-Hodgkin's lymphoma
    Rodriguez, J
    Caballero, MD
    Solano, C
    Lahuerta, JJ
    Arranz, R
    Sureda, A
    Zuazu, J
    Marin, J
    García-Laraña, J
    López-Guillermo, A
    SanMiguel, J
    Conde, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S260 - S261
  • [13] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Kwonoh Park
    Dok Hyun Yoon
    Shin Kim
    Chan-Sik Park
    Jooryung Huh
    Sang-Wook Lee
    Cheolwon Suh
    International Journal of Hematology, 2013, 97 : 256 - 262
  • [14] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
    Park, Kwonoh
    Yoon, Dok Hyun
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 256 - 262
  • [15] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    Akhtar, S.
    Elhassan, T. A. M.
    Edesa, W.
    Rauf, M. S.
    Zahir, M. N.
    Maghfoor, I.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 49 - 54
  • [16] High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma
    S. Akhtar
    T. A. M. Elhassan
    W. Edesa
    M. S. Rauf
    M. N. Zahir
    I. Maghfoor
    Annals of Hematology, 2016, 95 : 49 - 54
  • [17] High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults
    Greb, A.
    Bohlius, J.
    Schiefer, D.
    Schwarzer, G.
    Schulz, H.
    Engert, A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [18] Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma
    Gerrie, Alina S.
    Power, Maryse M.
    Savage, Kerry J.
    Shepherd, John D.
    Connors, Joseph M.
    BLOOD, 2011, 118 (21) : 884 - 885
  • [19] Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study
    Castagna, Luca
    Magagnoli, Massimo
    Balzarotti, Monica
    Sarina, Barbara
    Siracusano, Licia
    Nozza, Andrea
    Todisco, Elisabetta
    Bramanti, Stefania
    Mazza, Rita
    Russo, Filippo
    Timofeeva, Inna
    Santoro, Armando
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (02) : 122 - 127
  • [20] Rituximab and Interleukin 2 (IL2) as treatment for CD20+non-Hodgkin's lymphoma (NHL) following autologous peripheral blood stem cell transplant (ASCT).
    Holmberg, LA
    Maloney, DG
    Bensinger, WI
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 566S - 566S
12345